Liver Health and Biological Age

What does the liver do?

The liver performs hundreds of functions that support everyday life.

Among its most important roles, it helps:

• process carbohydrates, fats, and proteins
• regulate blood glucose
• produce and package cholesterol and triglycerides
• store glycogen, vitamins, and minerals
• produce albumin and clotting proteins
• make bile for digestion
• process alcohol and many medications
• convert ammonia and other waste products into forms the body can remove
• support immune regulation
• respond to injury and regenerate tissue

This wide range of responsibilities explains why liver health can affect many parts of the body.

It also explains why liver-test abnormalities can have many possible causes.

How is liver health connected to biological age?

Biological age estimates how the body is functioning compared with what is typical for a person’s chronological age.

The liver is relevant because it sits at the center of metabolic health.

With aging, the liver may experience changes in:

• blood flow
• mitochondrial function
• fat metabolism
• cellular repair
• regenerative capacity
• immune signaling
• inflammation
• susceptibility to fibrosis
• the processing of medications and toxins

The extent of these changes differs substantially between people.

Metabolic dysfunction, excess liver fat, alcohol exposure, viral hepatitis, certain medications, genetics, and other conditions can place additional stress on the liver and may contribute to less healthy aging.

Liver-related biomarkers also appear in some clinical biological-age models. Albumin and alkaline phosphatase, for example, are included in Phenotypic Age.

That does not make them pure measurements of liver aging:

• Albumin can also be affected by inflammation, kidney disease, nutrition, and fluid balance.
• Alkaline phosphatase can come from the liver, bile ducts, bone, and other tissues.

These markers contribute information as part of a larger pattern. They should not be interpreted as a direct “liver age.”

What do routine liver blood tests measure?

A standard liver panel may contain several types of markers.

They do not all answer the same question.

Some mainly indicate possible cell injury or bile-flow disturbance. Others provide information about the liver’s ability to perform its functions.

ALT

Alanine aminotransferase, or ALT, is an enzyme found primarily in liver cells.

When liver cells are irritated or damaged, ALT can leak into the bloodstream.

ALT may rise with:

• metabolic dysfunction-associated steatotic liver disease
• viral hepatitis
• alcohol-related liver injury
• medication or supplement effects
• autoimmune liver disease
• reduced blood flow to the liver
• other liver conditions

ALT is more liver-specific than AST, but it is not perfectly specific.

A mildly elevated ALT does not reveal the cause by itself. It also does not show how much fibrosis is present.

Importantly, people with significant fatty liver or fibrosis can sometimes have ALT values within the laboratory reference range.

AST

Aspartate aminotransferase, or AST, is found in the liver but also in:

• skeletal muscle
• heart muscle
• red blood cells
• other tissues

AST may rise because of liver injury, but it can also increase after:

• strenuous exercise
• muscle damage
• hemolysis
• certain heart conditions
• other non-liver causes

This makes AST less liver-specific than ALT.

The relationship between AST and ALT may sometimes provide context, but the ratio alone cannot diagnose the cause of an abnormal result.

For example, AST may exceed ALT in alcohol-related liver disease, advanced fibrosis, or muscle injury. The same pattern can arise for different reasons, so it should never be interpreted without the wider clinical picture.

GGT

Gamma-glutamyl transferase, or GGT, is an enzyme associated with the liver and bile ducts.

GGT may rise with:

• alcohol exposure
• metabolic liver disease
• bile-duct problems
• certain medications
• oxidative stress
• other liver conditions

It is sensitive, but not highly specific.

One useful role of GGT is helping interpret alkaline phosphatase. When both ALP and GGT are elevated, the source of the ALP elevation is more likely to be hepatobiliary rather than bone-related.

An isolated GGT elevation does not prove that alcohol is the cause. It also does not diagnose fatty liver or fibrosis.

Alkaline phosphatase

Alkaline phosphatase, or ALP, is found in several tissues, especially:

• bile ducts
• liver
• bone
• placenta
• intestine

An elevated ALP can occur when bile flow is obstructed or impaired, but it can also rise because of bone growth, bone disease, pregnancy, healing fractures, or other causes.

This is why ALP should be interpreted alongside GGT, bilirubin, symptoms, age, and the rest of the blood panel.

ALP is included in Phenotypic Age, but its biological-age association should not be described as exclusively reflecting liver health.

Bilirubin

Bilirubin is produced when the body breaks down old red blood cells.

The liver processes bilirubin and helps excrete it through bile.

Higher bilirubin may result from:

• increased red blood cell breakdown
• reduced liver processing
• impaired bile flow
• inherited conditions such as Gilbert syndrome
• liver or biliary disease

Bilirubin may be reported as:

• total bilirubin
• direct or conjugated bilirubin
• indirect or unconjugated bilirubin

The pattern can help narrow possible explanations, but it does not provide a diagnosis by itself.

A mildly elevated bilirubin with otherwise normal tests may have a very different meaning from an elevation accompanied by abnormal ALP, ALT, AST, or symptoms.

Albumin

Albumin is the most abundant protein in the blood and is produced by the liver.

It helps:

• maintain fluid within blood vessels
• transport hormones, medications, fatty acids, and other substances
• reflect aspects of nutritional, inflammatory, kidney, and liver health

Low albumin can occur with advanced chronic liver dysfunction, but it can also result from:

• inflammation
• kidney protein loss
• malnutrition or malabsorption
• severe illness
• fluid overload
• other medical conditions

Albumin usually changes more slowly than liver enzymes. It is therefore more relevant to sustained liver synthetic function than to a short episode of liver-cell irritation.

Albumin is included in Phenotypic Age, but its broad biological meaning extends beyond the liver.

Clotting measurements

The liver produces many proteins involved in blood clotting.

Tests such as prothrombin time and INR can provide information about liver synthetic function, particularly in acute or advanced liver disease.

However, INR can also be affected by:

• anticoagulant medication
• vitamin K deficiency
• malabsorption
• other clotting disorders

These tests are not always included in routine wellness blood work.

Platelets

Platelets are measured in a complete blood count rather than a liver panel.

A low platelet count can sometimes occur in advanced chronic liver disease because of portal hypertension, changes in the spleen, and reduced production of thrombopoietin.

But low platelets have many other possible causes.

Platelet count becomes particularly useful when combined with age, AST, and ALT in non-invasive fibrosis scores such as FIB-4.

Liver enzymes are not the same as liver function

The phrase “liver function tests” is widely used, but it can be misleading.

ALT and AST mainly indicate possible cell injury. They do not directly measure how well the liver is performing its many functions.

GGT and ALP can provide clues about the liver and bile ducts, but they also do not measure total liver performance.

Albumin, bilirubin, and clotting measurements provide more direct information about aspects of liver function, although they too can be influenced by conditions outside the liver.

A useful mental model is:

Possible injury or stress

• ALT
• AST
• GGT
• ALP

Processing and synthetic function

• Bilirubin
• Albumin
• PT/INR

Additional context

• Platelets
• Glucose and HbA1c
• Triglycerides and HDL
• Ferritin
• Complete blood count
• Imaging and fibrosis testing

No single group provides the complete picture.

What is fatty liver disease?

Fat can accumulate inside liver cells.

When this occurs alongside metabolic risk factors, the condition is now called metabolic dysfunction-associated steatotic liver disease, or MASLD. It was previously known as non-alcoholic fatty liver disease, or NAFLD.

MASLD is closely associated with:

• excess body fat, particularly visceral fat
• insulin resistance
• type 2 diabetes
• elevated triglycerides
• high blood pressure
• other features of metabolic dysfunction

Some people have liver fat without major inflammation or scarring. Others develop inflammation and progressive fibrosis.

Fibrosis matters because it reflects scar-tissue accumulation. Advanced fibrosis and cirrhosis carry substantially greater risks than liver fat alone.

Many people with MASLD have no obvious symptoms. Routine liver enzymes can also be normal, which means blood tests cannot reliably rule it out.

Can routine blood tests detect liver fibrosis?

Routine blood tests can help estimate fibrosis risk, but they cannot directly confirm or stage fibrosis in every person.

One commonly used score is FIB-4, which combines:

• chronological age
• AST
• ALT
• platelet count

FIB-4 is primarily a risk-stratification tool. It is often used to identify people who are unlikely to have advanced fibrosis and those who may need additional testing.

It has important limitations:

• Age is built into the score.
• Performance differs in younger and older adults.
• Acute illness or temporary enzyme elevations can distort it.
• A low result does not exclude every case of significant fibrosis.
• A high result does not prove that advanced fibrosis is present.

Further assessment may involve:

• elastography, such as FibroScan
• ultrasound
• enhanced blood-based fibrosis tests
• MRI-based methods
• specialist evaluation
• occasionally liver biopsy

Because FIB-4 already contains chronological age, it should not be treated as an independent biological-age marker.

Can normal liver enzymes rule out liver disease?

No.

This is one of the most important misconceptions about liver testing.

ALT and AST can be normal in people with:

• steatotic liver disease
• significant fibrosis
• chronic hepatitis
• other liver conditions

Conversely, elevated enzymes may be temporary and may not reflect chronic liver disease.

Normal liver enzymes are reassuring, but they are not a guarantee that the liver contains no excess fat, inflammation, or fibrosis.

Risk factors, changes over time, imaging, metabolic markers, medication history, alcohol use, and other clinical information all matter.

What can temporarily change liver-test results?

Liver-related biomarkers can change because of recent or temporary circumstances.

Examples include:

• viral or other infections
• strenuous exercise
• muscle injury
• dehydration
• alcohol consumption
• a recent medication change
• supplements or herbal products
• rapid weight change
• gallstones
• fasting or nonfasting status
• laboratory variation
• acute illness

Intense exercise can increase AST and sometimes ALT because these enzymes are also present in muscle.

A single abnormal result should therefore be interpreted in context. Persistently abnormal tests or substantial changes deserve professional evaluation.

What influences long-term liver health?

Metabolic health

Blood sugar regulation, triglycerides, visceral fat, and liver health are tightly connected.

Insulin resistance can promote fat accumulation in the liver. In turn, excess liver fat can contribute to impaired glucose and lipid regulation.

Improving metabolic health is therefore one of the most important ways to support the liver.

Nutrition

No single food “detoxes” the liver.

The liver already performs detoxification continuously.

A liver-supportive dietary pattern generally emphasizes:

• vegetables and fruit
• legumes
• whole grains
• nuts and seeds
• fish and appropriate protein sources
• unsaturated fats
• minimally processed foods

Reducing excess calories, highly refined carbohydrates, sugar-sweetened drinks, and heavily processed foods may be particularly helpful when metabolic liver disease is present.

The most effective dietary pattern is one a person can sustain.

Physical activity

Regular exercise can reduce liver fat and improve insulin sensitivity, even when weight loss is modest.

Both aerobic exercise and resistance training can be useful.

The goal does not need to be extreme. Consistent movement across the week is more valuable than an occasional intense effort followed by prolonged inactivity.

Body composition

For people with overweight, obesity, or excess visceral fat, sustainable weight loss can meaningfully reduce liver fat.

Larger degrees of weight loss may also improve inflammation and fibrosis in some people with MASLD, but recommendations should be individualized.

Rapid crash diets are not necessary and may be difficult to maintain.

People at lower body weights can also develop MASLD, particularly when genetic or metabolic risk factors are present.

Alcohol

Alcohol can affect liver fat, inflammation, fibrosis, blood pressure, sleep, triglycerides, and cancer risk.

The effect depends on:

• amount
• frequency
• drinking pattern
• sex
• body size
• genetics
• medications
• existing liver disease
• metabolic health

People with liver disease may need to avoid alcohol entirely. There is no reason to begin drinking for health benefits.

Medications and supplements

Many medications are processed by the liver.

Most prescribed medicines are safe when used correctly, but some can affect liver tests or cause liver injury.

Supplements deserve equal caution. “Natural” does not mean harmless. Some herbal, bodybuilding, weight-loss, and concentrated nutritional products have been linked to liver injury.

Do not stop prescribed medication because of an isolated abnormal test without consulting the prescribing clinician.

Viral hepatitis and other conditions

Hepatitis B and C can cause chronic liver disease, sometimes without symptoms.

Other causes include:

• autoimmune liver disease
• hereditary hemochromatosis
• Wilson disease
• bile-duct disorders
• medication-related injury
• alcohol-related liver disease
• genetic conditions

Lifestyle improvement is valuable, but it cannot replace appropriate investigation and treatment when another cause is present.

Can liver health and biological age improve?

The liver has a strong capacity to recover, particularly when injury is identified before advanced scarring develops.

Depending on the cause, improvement may follow:

• better blood sugar regulation
• regular physical activity
• sustainable weight loss when appropriate
• reduced liver fat
• avoiding or reducing alcohol
• stopping smoking
• treating viral hepatitis
• addressing high triglycerides
• reviewing medications and supplements
• managing blood pressure
• receiving condition-specific medical care

Liver enzymes may improve before fibrosis changes, and normalizing an enzyme does not necessarily prove that all liver injury has resolved.

Advanced fibrosis may improve in some circumstances, but cirrhosis can have lasting consequences and requires medical care.

The goal should not be to lower ALT or GGT merely to create a younger-looking score.

The goal is to improve the underlying metabolic, inflammatory, vascular, and liver physiology that the biomarkers reflect.

Improved albumin, ALP, or other liver-related results may affect a clinical biological-age estimate, depending on the model used. But changing one biomarker does not prove that the entire aging process has been reversed.

How BioKarma uses liver-related biomarkers

When available in an uploaded report, BioKarma evaluates markers such as:

• ALT
• AST
• GGT
• alkaline phosphatase
• albumin
• bilirubin
• platelets
• glucose and HbA1c
• triglycerides and other related biomarkers

BioKarma considers these results alongside inflammation, kidney function, cardiovascular health, blood-cell measurements, and the rest of the available profile.

The free analysis helps explain:

• your estimated biological age
• which available biomarkers appear favorable
• which results may be influencing the estimate
• where additional attention may be useful

BioKarma does not diagnose fatty liver disease, fibrosis, hepatitis, alcohol-related liver disease, or another medical condition.

Normal liver enzymes do not allow BioKarma to rule out liver fat or fibrosis. Abnormal results also require clinical context before their cause can be understood.

Premium recommendations combine available biomarkers with lifestyle information such as nutrition, exercise, sleep, smoking, and alcohol use to provide more personalized guidance.

BioKarma provides wellness insights and is not a substitute for professional medical care. Persistently abnormal results, jaundice, dark urine, abdominal swelling, severe pain, confusion, vomiting, or other concerning symptoms require medical evaluation.

Look at the pattern, not one enzyme

A liver panel is most useful when viewed as a connected pattern.

Ask:

• Are ALT and AST elevated?
• Is the pattern persistent?
• Could exercise, muscle injury, illness, alcohol, medication, or supplements be contributing?
• Are GGT and ALP elevated together?
• Is bilirubin normal?
• Are albumin and platelets preserved?
• Do glucose, HbA1c, triglycerides, and body composition suggest metabolic risk?
• Is fibrosis assessment appropriate?
• Have the results changed over time?

Routine blood tests can reveal valuable clues about liver health and its relationship with metabolic and biological aging.

But the best interpretation combines enzymes, function markers, metabolic context, trends, and, when needed, additional testing.